Department of Health and Ageing and MSAC logos
image of a microscope

Application 1067

Genotypic resistance testing of antiretrovirals in HIV

Application No.1067
Application NameGenotypic resistance testing of antiretrovirals in HIV
Advisory PanelsProfessor Syd Bell
(Chair and MSAC Member)
Dr Ewa Piejko
(MSAC Member)
Associate Professor Andrew Carr
(Royal Australasian College of Physicians nominee)
Mr John Daye
(Consumer representative)
Dr Roger Garsia
(Royal College of Pathologists of Australasia nominee)
Dr Geoff Higgins
(Co-opted member)
Associate Professor Jennifer Hoy
(Australasian Society for HIV Medicine nominee)
Associate Professor Anne Mijch
(Australasian Society for Infectious Diseases nominee)
Professor Lloyd Sansom
(Chair, Pharmaceutical Benefits Advisory Committee - co-opted member)
Dr Ruth Lopert
(Department of Health and Ageing - Observer)
Date Received by MSAC SecretariatJuly 2003
Stage 1 - EligibilityEligible
Stage 2 - AssessmentCompleted
Stage 3 - Formulation of Advice to the MinisterThis assessment was considered by the MSAC at the 17 November 2004 meeting.

Genotypic resistance testing of antiretrovirals in HIV appears to be safe and leads to changes in the clinical management but there is insufficient evidence on effectiveness and cost-effectiveness to support Medicare funding.
Stage 4 - DecisionEndorsed by the Minister 2 March 2005
Stage 5 - Implementation
Top of page